Sickle Cell Disease (SCD): Practice Essentials, Background, Genetics



elevated von willebrand factor and factor 8 :: Article Creator

Infected Blood Scandal: Tainted Medication Was Kept In Family's Fridge

Image caption,

Jack Edwards had two young children, Louise and David, when he died of Aids-related illnesses caused by infected blood

By Chris Baynes & Jamie Coulson

BBC Yorkshire Investigations

As a child, Louise Edwards thought nothing of seeing vials of blood plasma in her family's fridge.

Every couple of days, her father Jack would take a bottle from the salad drawer and inject its contents into his body.

The vials contained Factor VIII, a potentially life-saving treatment for his haemophilia. But the same medication would ultimately lead to his death.

His family, from Leeds, would come to learn some batches of the clotting agent given to Mr Edwards had been contaminated with deadly diseases.

Mr Edwards was infected by doses tainted with hepatitis C and HIV. He died of Aids-related illnesses in 1985 at the age of 47.

His daughter, who was only 12 at the time, told the BBC it felt like her "world had ended" when she lost her father.

Image caption,

Louise Edwards was 12 when her father Jack died of Aids-related illnesses

"I was a complete daddy's girl. Wherever my dad went, I was usually two steps behind him," Ms Edwards said.

The 50-year-old added: "He was a proper family man who would do anything for his kids.

"When he died, there was a massive hole left and it's never been filled."

Mr Edwards was one of more than 30,000 NHS patients who were infected with diseases from contaminated blood products and transfusions during the 1970s and 1980s.

The scandal has led to the deaths of an estimated 2,900 people in the UK.

Ms Edwards said she still "can't comprehend" the events which caused her father to die.

Image caption,

Louise Edwards said her father's death "should have been prevented"

Mr Edwards, a warehouse foreman who also had a young son, David, with his wife Margaret, began receiving Factor VIII from St James's Hospital in Leeds to treat his haemophilia in the 1970s.

Due to a shortage of blood supplies, the UK government imported Factor VIII from the US, where much of it was made from blood bought cheaply from high-risk donors such as prison inmates and drug users.

Whole batches of the treatment - which were not initially screened for infections - were contaminated with diseases.

On 20 May, a public inquiry will publish its findings into what has been called the largest treatment disaster in the health service's history.

Ms Edwards, who gave evidence to the inquiry, said she hoped the report would "finally give us answers" about "why it was decided it was acceptable to put people's lives at risk".

She added: "I lost my dad and we lost so many people.

"It could have been prevented. And it should have been prevented."

Image caption,

Jack Edwards was never warned Factor VIII could expose him to infections

Ms Edwards said stigma around HIV in the 1980s meant she felt unable to publicly grieve her father's death.

She added her father was never warned Factor VIII could put him at risk.

"It always lived in the bottom of our fridge. It was completely normal," she said.

'Miserable and ill'

Sue Harrison, 74, from Sheffield, was injected with Factor VIII during a hospital test in 1976.

The check - for Von Willebrand disease, a blood disorder her mother carried - was negative and she received no further contact from Sheffield Royal Infirmary.

Thirty-two years later, after a routine blood test in Cyprus, she learned she had hepatitis C.

Image source, Factor 8/Marc marnie Image caption,

Thousands of people were infected with diseases by contaminated batches of Factor VIII

Mrs Harrison said she and her husband Trevor had bought a "dream" holiday home in northern Cyprus as part of their retirement plans.

But after the test result she was branded an "undesirable immigrant" and forced to leave the country, which does not grant residence to anyone with certain diseases, including hepatitis C and HIV.

She said: "I had to hand my passport over to the police and they advised me and my husband to get a flight out as soon as possible because otherwise the army would take me.

"That had huge ramifications about my own self-worth and self-confidence.

"I felt dirty, inside and out."

The former nursery teacher added she initially had no idea "how I could have even had hepatitis C".

Image caption,

Sue Harrison was forced to leave Cyprus because she had Hepatitis C

Mrs Harrison has been clear of the virus since 2010 after enduring more than a year of treatment which she said left her "feeling completely miserable and ill all the time".

"I was feeling so ill I did say to my husband, 'I won't kill myself, kid, but if I go to bed and go to sleep and never wake up again, it'll be fine,'" she told the BBC.

Mrs Harrison gave evidence in person to the inquiry in 2019 and said she wanted to speak out for people who could not.

"I've met a number of people in support groups who have been instrumental in helping me get through the worst of times," she added.

"I want to speak out on behalf of that community. Children who have lost parents and parents who have lost children. Which should never, ever have happened. The government, in the late 1970s and early 1980s, had the power to stop all this and chose to save money, not lives."

'Absolutely horrific'

About 26,800 people were infected with hepatitis C through blood transfusions following childbirth, surgery or other medical treatment between 1970 and 1991, according to the inquiry.

By 2022, an estimated 1,820 of those patients had died as a result.

Norman Revill, from York, was infected with hepatitis C during a blood transfusion after an accident in 1983 and said it had been "absolutely horrific" to see other patients "die around you".

While he is now clear of the virus after 18 months of gruelling treatment, the 66-year-old said the impact on him had been "absolutely devastating" both physically and mentally.

Image caption,

Norman Revill said watching other patients die around him had been "devastating"

He told the BBC: "Above all one of the things that really has affected me is the mental anguish I've felt when people around me have died. I think to myself, why have I not?"

Mr Revill added: "I want everybody to be aware of what a tragedy this has been, I want everyone to understand how poorly it's been handled over the last 50 years - the pain and the suffering and the heartbreak that so many people have gone through."

'Appalling tragedy'

The government has been widely accused of dragging its feet over compensation to people affected by the infected blood scandal.

The Haemophilia Society said a further 100 victims had died since the inquiry's chair, Sir Brian Langstaff, told ministers in April 2023 to "act quickly" to set up a compensation framework.

The government has previously said it would be "inappropriate" to consider final payments ahead of the inquiry's full report but last week announced plans to establish an independent compensation body.

A government spokesperson said: "This was an appalling tragedy, and our thoughts remain with all those impacted.

"We have consistently accepted the moral case for compensation, and that's why we have tabled an amendment to the Victims and Prisoners Bill which enables the creation of a UK-wide Infected Blood Compensation Scheme and establishes a new arms-length body to deliver it.

"We will continue to listen carefully to those infected and affected about how we address this dreadful scandal."

Related Internet Links

The BBC is not responsible for the content of external sites.


Desmopressin - Uses, Side Effects, And More

Who should not use desmopressin?

Allergies to Ingredients. People who are allergic to any of the following should not take desmopressin products.

  • Desmopressin
  • DDAVP
  • Nocdurna
  • Any of the ingredients in the specific product dispensed
  • Your pharmacist can tell you all of the ingredients in the specific desmopressin products they stock.

    Heart Failure. Desmopressin should not be taken if you have heart failure. Desmopressin can cause fluid retention, which can worsen heart failure.

    Uncontrolled Blood Pressure (Hypertension). Desmopressin should not be taken if you have uncontrolled blood pressure. Desmopressin can cause fluid retention, which can worsen hypertension. Make sure that you know if you have high blood pressure and if it has been successfully lowered with medicine before taking desmopressin.

    Low Sodium (Hyponatremia). Desmopressin may cause a low sodium level. Do not take desmopressin if you have or have had low blood sodium levels or if you have any of the following conditions because of an increased risk of hyponatremia.

  • Excessive thirst (polydipsia)
  • Illnesses that can cause you to lose a lot of water from a fever, diarrhea, or vomiting 
  • A condition called syndrome of inappropriate antidiuretic hormone secretion (SIADH)
  • A kidney problem that causes you to have low salt levels
  • Kidney Problems. Desmopressin should not be taken if your kidneys are not working as well as they should be. If there is a concern about the health of your kidneys, your healthcare provider may do tests to determine if they are working well enough to take this medicine.

    Drug Interactions. Desmopressin should not be taken while you are using certain other medicines. Before taking desmopressin, tell your healthcare provider about any prescription or over-the-counter (OTC) medicines, vitamins/minerals, herbal products, and other supplements you are using. See the Interactions section below for more details.

    What should I know about desmopressin before using it?

    Do not take desmopressin unless it has been prescribed to you by a healthcare provider. Take it as prescribed.

    Do not share desmopressin with other people, even if they have the same condition as you. It may harm them.

    Keep desmopressin out of the reach of children.

    If you take desmopressin to reduce the amount of pee made because you are waking at night to pee, limit the amount of water or other liquids you drink from an hour before taking desmopressin to 8 hours after taking it.

    Desmopressin can affect your alertness or coordination. Do not drive or do other activities that require alertness or coordination until you know how desmopressin affects you.

    Children and people who are 65 years of age or older can be at greater risk for some side effects of desmopressin. Talk to your healthcare provider about your risks if you are in this age group.

    What should I tell my healthcare provider before using desmopressin?

    Tell your healthcare provider about all of your health conditions and any prescription or over-the-counter (OTC) medicines, vitamins/minerals, herbal products, and other supplements you are using. This will help them determine if desmopressin is right for you.

    In particular, make sure that you discuss any of the following.

    Current and Past Health Conditions. Tell your healthcare provider if you have any of the following health conditions.

  • von Willebrand's disease Type IIB
  • Kidney problems
  • High blood pressure
  • Heart disease
  • An infection, fever, vomiting, or diarrhea
  • Increased pressure in your brain (intracranial pressure)
  • Trouble peeing (urinary retention)
  • Cystic fibrosis
  • History of blood clots (injection)
  • Pregnancy. It is not known if or how desmopressin could affect pregnancy or harm an unborn baby. Tell your healthcare provider if you are or plan to become pregnant. Your healthcare provider will advise you if you should take desmopressin while you are pregnant or trying to get pregnant.

    Breastfeeding. Desmopressin may pass into breast milk. Tell your healthcare provider if you are breastfeeding or plan to breastfeed. Your healthcare provider will advise you if you should take desmopressin while breastfeeding.


    The Laboratory Investigation Of Von Willebrand Disease

    Date:  April 26, 2023

    Time: 11:00am (PDT),  2:00pm (EDT), 8:00pm (CEST)

    Von Willebrand disease is one of the most common bleeding disorders that affects both men and women equally. However, the diagnosis of von Willebrand disease has often been challenging due to broad clinical presentation and variability in testing methods- e.G. Ristocetin cofactor activity. Today you will learn more about the laboratory investigation of von Willebrand disease, focusing on the different tests involved in the diagnosis. In his presentation our speaker will discuss the new guidelines for diagnosis and newer assays for von Willebrand factor activity.

    Speaking on this topic, Dr. John Mitsios, Medical Sciences Partner at Siemens Healthineers, will help you to:

  • Describe the different stages of hemostasis
  • Describe the first line testing for von Willebrand Disease
  • Describe the second line testing for von Willebrand Disease
  • Webinars will be available for unlimited on-demand viewing after live event.

    Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.






    Comments

    Popular posts from this blog

    Well-liked Medicare plan vs. higher-ranked providers - ChicagoNow

    Minnesota veterans blame 3M's 'defective' ear plugs for hearing damage - KSTP

    Sickle Cell Disease (SCD): Practice Essentials, Background, Genetics